Iambic Therapeutics, Inc. (IAM)
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Iambic Therapeutics Inc.
No financial data available.
No debt & equity data available.
No splits on record
Nothing in IAM's public trading history: no forward or reverse split has affected the share count.
No balance sheet details available.
No income statement data available.
No balance sheet data available.
No cash flow data available.